Is Sarcopenia the New Smoking?

FREE WEBINAR: Is sarcopenia the new smoking? 

Wednesday 22nd April 2026 | 7pm- 8pm (AEST)

We are very excited to announce the upcoming webinar jointly hosted by the Australian and New Zealand Head and Neck Cancer Society and Head and Neck Cancer Australia which seeks to answer the question: Is sarcopenia the new smoking?

Loss of skeletal muscle is increasingly recognised as a major determinant of outcomes for patients with Head and Neck Cancer, influencing treatment tolerance, complications, functional recovery and survival. Clinicians are also navigating overlapping and interacting constructs including sarcopenia, malnutrition, cachexia and frailty, which together contribute to patient vulnerability across the cancer care continuum.

This webinar will provide an evidence-based update on muscle health in Head and Neck Cancer, including advances in body composition assessment, emerging treatment implications, and the evolving literature of the impact of sarcopenia on outcomes including survival. The keynote will be followed by a multidisciplinary discussion focused on translating evidence into practice, including practical strategies to optimise outcomes through multidisciplinary care including nutrition and exercise interventions.

Who should attend?
This webinar will be relevant to multidisciplinary clinicians and researchers working in Head and Neck Cancer with an interest in muscle health and its implications for treatment tolerance, functional recovery, and survival, including allied health professionals, nurses, oncologists and surgeons.